Compare Berkshire Hathaway Inc Class B (BRK.B) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Berkshire Hathaway Inc Class B vs Zoetis Inc — how do they compare? Berkshire Hathaway Inc Class B trades at $488.73, while Zoetis Inc trades at $74.4 (market cap $31.05B). The key difference: Zoetis Inc pays a 2.86% dividend while Berkshire Hathaway Inc Class B pays none, and Berkshire Hathaway Inc Class B is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.
| BRK.B | ZTS | |
|---|---|---|
Sector | Financials | Health |
52-Week High | $513.70 | $156.76 |
52-Week Low | $459.10 | $71.91 |
Market Cap | — | $31.05B |
Enterprise Value | — | $38.35B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Berkshire Hathaway Class B shares (BRK.B) trade at $488.50, down 1.67% today, with a bullish technical signal from moving averages and oversold RSI at 14.57. Analyst consensus is positive with 57% buy ratings, though key valuation ratios like P/E and P/B are unavailable in the provided data. Recent earnings have shown resilience in the conglomerate's diversified holdings.
The outlook remains favorable given strong institutional support and the company's robust cash flow, but risks include market volatility and economic downturns affecting its broad portfolio. Upside potential hinges on continued operational execution and strategic acquisitions under Warren Buffett's leadership.
Zoetis (ZTS) trades at $75.39, down 0.22% with bearish technical signals and mixed sentiment. The company maintains strong fundamentals with $9.47B revenue, 28.03% net margin, and robust profitability metrics (ROE 67.75%, ROA 18.27%). Recent Q1 2026 earnings missed expectations, while multiple law firms have filed class action lawsuits alleging securities violations between January 2025 and May 2026.
Despite strong financials and analyst consensus price target of $101.43 (34.5% upside), ZTS faces significant legal risks and technical weakness. The stock presents a value opportunity for long-term investors willing to navigate near-term volatility, though the class action lawsuits create substantial uncertainty for shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Berkshire Hathaway Inc Class B
Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.
Read more on BRK.B →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
